Patent ID: 7166573
Filing Date: 2007-01-23
Classification: A61P,G01N

Abstract:
1. A method of diagnosing prostate cancer comprising: contacting a biological sample isolated from a subject with an antibody or antigen binding fragment thereof that specifically binds with an expression product of a nucleic acid molecule, which is (a) a nucleic acid molecule that encodes a polypeptide having at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 1218, (b) a nucleic acid molecule that differs from SEQ ID NO: 504 in codon sequence due to degeneracy of the genetic code, or (c) a full length complement of (a) or (b), and determining the interaction between the antibody or antigen binding fragment thereof and the expression product, wherein a determination that the antibody or antigen binding fragment thereof interacts with the expression product indicates that the expression product is present in the sample and that the patient has prostate cancer.